Since the end of February, shares of Cosmos Holdings (NASDAQ: COSM) are available for trading on the Nasdaq Stock Market.
Cosmos Holdings (COSM) raised $6 million in February after it up-listed to the Nasdaq Stock Market, reaching a “historic milestone” for the company.
The listing comes after Cosmos CEO Greg Siokas converted $6 million of debt the company owed him into common shares at $6 apiece. At the time, COSM stock price averaged $4-$5 and the conversion reinforced the company’s balance sheet.
Although purchasing shares of your own company is an uncommon practice among company executives, it is typically viewed as a strong investment indicator.
Shares closed nearly 3% higher on the Nasdaq debut and were up nearly 20% at one point of the day. Since then, COSM stock has moved lower to now trade at 18-month lows, or just around the $2 handle.
The international pharmaceutical company has a market cap of just over $35 million.
New Pharmaceutical Products
The company has created an innovative formula designed to improve brain function. The number of brain-related diseases such as dementia, Parkinson’s, and depression has increased over the past recent years. Still, there is a significant lack of effective treatments for these diseases.
“With the global population aging, there is increased demand for high-quality brain health supplements that can enhance memory, improve brain function and health,” said Siokas.
A recent report by Fortune Business Insight showed that the Covid-19 pandemic has battered multiple global industries. Yet, it has also “presented a tremendous growth opportunity” in other sectors, including nutraceuticals.
Nutraceuticals are substances that have physiological benefits or provide protection against chronic diseases. Nutraceuticals may be used to improve health, delay the aging process, prevent chronic diseases, or support the body and mind.
The demand for health-boosting products skyrocketed following the pandemic outbreak. Fortune Business Insight predicts this market to grow from $352.9 billion in 2021 to $658.1 billion in 2028.
European analysts expect the nutraceuticals market to hit $108 billion by 2027, from its estimated worth of $59.3 billion in 2018.
Furthermore, the researchers estimate the U.S. market at $104.5 billion in 2021 and expect the China market to hit $52.5 billion by 2026. Researchers claim that nutraceuticals represent a “vital link between health and food.”
COSM Business Expectations
Cosmos is looking to achieve 2022 revenue growth in the range of 15-20% to more than $65 million and a gross margin increase to 18%.
The company also intends to launch 40 to 50 new sophisticated nutraceutical products, including the SPL Mediterranean Line expected in the second quarter of this year.
Additionally, Cosmos plans to launch Amazon Stores in European countries including Italy, Germany, Spain, and France, as well as Singapore, Brazil, and the U.S. in the second half of the year.
The company plans to introduce its SPL store on China’s largest cross-border B2C online marketplace, Tmall Global, this spring.
In its outline of future plans, Cosmos said it wants to increase the management headcount. The company aims to support its aggressive growth strategy, add new board members, and set up an advisory board.
Cosmos also said it will focus on mergers and acquisitions (M&A) as well as joining venture (JV) deals. The company plans to strike strategic partnerships that will help expand its geographic footprint and market share, as well as increase operational efficiency and market penetration.
Cosmos Holdings (COSM) shares are now available for trading on the Nasdaq Stock exchange. The listing will further increase the company’s transparency and provide investors with access to investing in a growing pharmaceutical company.
Want to see if we think Cosmos Holdings (COSM) is a good stock to buy? Learn more.
Beat The Market With Our Expert Stock Picks
If you invested in 10 of our featured stock picks over the last 5 years, your chances of beating the market would be 90%.
Our last 3 stock picks grew a combined 348% after our alert!
Want to be notified the next time we issue a “Big Buy” alert or update our stocks to buy list? Sign up below today.
Following recent media reports that the healthcare company CVS Health Corp (NYSE: CVS) is in advanced discussions to acquire home-healthcare provider Signify Health (NASDAQ: SGFY) for roughly $8 billion, two companies confirmed the deal on Monday. CVS agreed to...
Nvidia shares dropped on Wednesday after the United States government limited sales of top AI chips to China. The tech company claims that its A100 and H100 high-performance AI chips would be impacted by the limitation in order to lessen the possibility that the...
September 6, 2022, World Wrestling Entertainment (NYSE: WWE) and Live Nation Entertainment, Inc. (NYSE:LYV) These two entertainment juggernauts have all the catalysts in the world pushing them as the best stocks to buy now. Just because American markets were closed on...
On the first day on the job, Oliver Blume informed the public that Volkswagen will quicken its transition to electric vehicles (EVs), but that the company has to find the correct "rhythm" as it makes the necessary changes. Blume revealed a ten-point strategy...
Lululemon Athletica shares increased by roughly 9% in after-hours trading Thursday, as the company announced quarterly earnings and revenue that exceeded analysts' estimates. U.S.-Canadian retailer reported better-than-expected results despite rising costs hurting...
Shares of Best Buy (NYSE: BBY) are down over 5% this week after the retailer reported a 13% drop in sales for the second quarter on Tuesday as consumers grew weary of inflation-driven price increases. How Did Best Buy Perform in Q1? Despite the sales...
September 2, 2022, Signet Jewelers Limited (NYSE:SIG) and Pure Storage, Inc. (NYSE:PSTG) Despite selling off following decent earnings, these two companies have considerable upside as the best stocks to buy now. As recession risks mount, the market is amid a...
Shares of the Chinese manufacturer of electric vehicles, XPeng (NASDAQ: XPEV), are trading over 20% lower in August after the EV company disclosed a wider-then-anticipated loss for the second quarter and disappointing delivery expectations. How Did XPeng...
September 1, 2022, Scorpio Tankers Inc. (NYSE:STNG) and EOG Resources, Inc. (NYSE:EOG) Singled out by a legendary growth investor, these energy standouts have more room to run as the best stocks to buy now. Investors appear to be in full-blown panic mode. The...
Shares of Dell Technologies (NYSE: DELL) fell to their lowest level since 2018 earlier this week after the technology company reported solid Q2 results but warned of a significant slowdown in the second half of the year as raging inflation continues to weigh on...